OpenVSafe by OpenVAERS
Search V-safe

YYE-53218-77305

3 vaccinations 2 coded responses 22 check-ins 2 free-text entries 1 call case
Sex
Male
Age at first dose
31-35
ZIP prefix
479 / IN
Registered
2021-01-10
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-09
    Dose 1 — Pfizer-BioNTech
  2. 2021-01-10
    Registered in v-safe
  3. 2021-01-10
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-01-15
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2021-01-16
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-01-23
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  7. 2021-01-28
    Dose 2 — Pfizer-BioNTech
  8. 2021-01-28
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  9. 2021-01-29
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Headache
    Adult check-in
  10. 2021-01-30
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  11. 2021-01-31
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  12. 2021-02-01
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  13. 2021-02-02
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  14. 2021-02-03
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  15. 2021-02-04
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  16. 2021-02-11
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-02-18
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-02-25
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-03-04
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-03-11
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-04-29
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-07-29
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-10-18
    Dose 3 — Pfizer-BioNTech
  24. 2022-01-28
    Survey response — 12 months, dose 2
    MedDRA: Angina pectoris, Chest pain, Pain — Feeling: Good
    Free text: Chest/heart has some mild dull pain that lasts intermittently.
    MedDRA releases: 2024-11 · check-in free text available
  25. 2022-04-21
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  26. 2022-10-18
    Survey response — 12 months, dose 3
    MedDRA: COVID-19, Candida infection, Emergency care, Office visit, Pharyngitis, Tonsillar hypertrophy, Viral infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit
    Free text: Symptoms: COVID mid-August 2022. Put on Paxlovid week of illness for 5 days. About 1 week following stopping Paxlovid, exp.'d significant COVID rebound. Then developed Thrush and 2 viral throat infections, causing tonsils to swell and needing steroid treatment · Healthcare visit (other): Had to see otolaryngologist (ENT doctor) twice, urgent care twice, ER once. Nearly had to have tonsils removed.
    MedDRA releases: 2024-11 · check-in free text available
  27. 2022-10-18
    Report sent to call center — 12 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
  28. 2022-10-19

Vaccinations

DoseDateManufacturerCo-administered
12021-01-09Pfizer-BioNTech
22021-01-28Pfizer-BioNTech
32021-10-18Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2022-10-18 Unsuccessful

Free text

Release 11 — 12 months, dose 2

2022-01-28

Symptoms: Chest/heart has some mild dull pain that lasts intermittently.

Release 12 — 12 months, dose 3

2022-10-18

Symptoms: COVID mid-August 2022. Put on Paxlovid week of illness for 5 days. About 1 week following stopping Paxlovid, exp.'d significant COVID rebound. Then developed Thrush and 2 viral throat infections, causing tonsils to swell and needing steroid treatment cut off by CDC
Healthcare visit (other): Had to see otolaryngologist (ENT doctor) twice, urgent care twice, ER once. Nearly had to have tonsils removed.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOEmergency care · · ✓
HCVOOffice visit · · ✓
SDAngina pectoris · · ✓
SDCandida infection · · ✓
SDChest pain · · ✓
SDCOVID-19 · · ✓
SDPain · · ✓
SDPharyngitis · · ✓
SDTonsillar hypertrophy · · ✓
SDViral infection · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release